Melinda Griffith joined Clarient as Senior Vice President, Corporate and Legal Affairs, in June 2010. Ms. Griffith also serves as Clarient’s Chief Compliance Officer and Secretary to the Board of Directors. From April, 2009 until June 2010, Ms. Griffith was a consultant to Clarient, providing assistance on a variety of transactions including the acquisition of Applied Genomics in December 2009. Before joining Clarient, Ms. Griffith served as the Executive Vice President, Corporate Development and General Counsel of Tethys Biosciences. Ms. Griffith joined Tethys from Roche Molecular Diagnostics, where, as Senior Vice President of Licensing and Law, she led the global licensing and legal activities for the worldwide leader in molecular diagnostics. A member of RMD's Executive Team, she directed the licensing programs of the PCR technologies and led successful initiatives to acquire rights to pioneer patent portfolios for HIV, Hepatitis C, Human Papilloma Virus, and micro-array technology. Before joining Roche, Ms. Griffith was head of legal and licensing affairs for Axys Pharmaceutical and Genelabs Technologies and began her biotechnology legal career at Cetus Corporation. She also was a corporate associate at the Bingham McCutchen law firm. Ms. Griffith received her B.S. in Business Administration from U.C. Berkeley and her J.D. from U.C. Hastings College of the Law. She is admitted to practice law in California and New York and is a frequent speaker on intellectual property licensing and litigation topics.
|